MCAD, crucial in fatty acid metabolism, does not have direct chemical activators but is influenced by compounds affecting lipid metabolism. Chemicals like Bezafibrate, Fenofibrate, and Clofibrate, belonging to the fibrate class, are known for enhancing fatty acid oxidation. They stimulate the breakdown of fatty acids, potentially increasing the substrate availability for MCAD in the mitochondria. This indirect effect is critical as MCAD's primary function is to catalyze the oxidation of medium-chain fatty acids, an essential process in energy production.
Additionally, L-Carnitine and Acetyl-L-Carnitine are vital in fatty acid metabolism. They facilitate the transport of long-chain fatty acids into mitochondria, indirectly enhancing the substrate pool available for MCAD. Compounds like Rosiglitazone and Pioglitazone, Thiazolidinediones, are involved in modulating lipid and glucose metabolism. By influencing these pathways, they can indirectly affect MCAD activity. PPAR agonists like WY-14643 and GW501516 also play a role in fatty acid metabolism, potentially impacting MCAD activity. Eicosapentaenoic Acid (EPA), an omega-3 fatty acid, influences lipid profiles, which could indirectly enhance MCAD's functional capacity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is a fibrate drug that stimulates fatty acid oxidation, which could indirectly enhance MCAD activity. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
L-Carnitine aids in transporting fatty acids into mitochondria, potentially increasing MCAD's substrate availability. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate, a fibrate drug, can increase the oxidation of fatty acids, potentially influencing MCAD activity. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate, a fibrate, may modulate lipid metabolism, potentially impacting MCAD. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Niacin influences lipid metabolism, potentially affecting fatty acid oxidation and MCAD activity. | ||||||
Acetyl-L-Carnitine | 3040-38-8 | sc-391881A sc-391881 | 250 mg 1 g | $143.00 $265.00 | 1 | |
This L-Carnitine derivative enhances fatty acid transport into mitochondria, potentially supporting MCAD activity. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone, a Thiazolidinedione, can influence lipid metabolism, potentially affecting MCAD. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, another Thiazolidinedione, may impact fatty acid metabolism, indirectly influencing MCAD. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
A PPAR-alpha agonist that may enhance fatty acid oxidation, indirectly affecting MCAD. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
A PPAR-delta agonist, known to influence lipid metabolism and potentially MCAD activity. | ||||||